Dr Kason Ashe, DO | |
123 Summer St, Worcester, MA 01608-1216 | |
(508) 363-5000 | |
Not Available |
Full Name | Dr Kason Ashe |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 123 Summer St, Worcester, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427578509 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 007759 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kason Ashe, DO 3131 E Hampton Ave, Mesa, AZ 85204-6335 Ph: () - | Dr Kason Ashe, DO 123 Summer St, Worcester, MA 01608-1216 Ph: (508) 363-5000 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Malformed desmin proteins aggregate with intact proteins of the same kind, thereby triggering skeletal and cardiac muscle diseases, the desminopathies. This was discovered by researchers from the RUB Heart and Diabetes Center NRW in Bad Oeynhausen led by PD Dr. Hendrik Milting in an interdisciplinary research project with colleagues from the universities in Karlsruhe, Würzburg and Bielefeld. They report in the Journal of Biological Chemistry.
Working with a group of national and international researchers, scientists from the Florida campus of The Scripps Research Institute have developed a new genetic model of premature aging disorders that could shed light on these rare conditions in humans and provide a novel platform for large-scale screening of compounds to combat these and other age-related diseases.
A drug used in the treatment of overactive bladder can accelerate atheroclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences.
Over $2.4 million has been committed by the National MS Society (USA) and the MS Society of Canada to support 7 new research projects focusing on the role of CCSVI in MS.
› Verified 1 days ago
Idris Z Dahod, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-7344 Fax: 508-363-7345 | |
Kissinger Hyppolite Fils, M.D General Practice Medicare: Medicare Enrolled Practice Location: 2 Marie St, Worcester, MA 01604 Phone: 401-688-7002 | |
Dr. Michael Sami Morrow, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-856-5740 Fax: 844-400-2598 | |
Wilfrid Gerard Pitts, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 10 Winthrop St, Worcester, MA 01604 Phone: 508-757-5552 | |
Waldo A. Zamor, MD General Practice Medicare: Medicare Enrolled Practice Location: 281 Lincoln St, Worcester, MA 01605 Phone: 508-334-1000 |